Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 552 Records) |
| Query Trace: Melanoma and BRAF[original query] |
|---|
| Clinical predictors of survival in real world practice in stage IV melanoma. Cancer reports (Hoboken, N.J.) 2022 9 e1691. Hu Hsien-Pang, Archer Christine, Yip Desmond, Peters Geoffr |
| Effects of BRAF V600E and NRAS mutational status on the progression-free survival and clinicopathological characteristics of patients with melanoma. Oncology letters 2023 Jan 25 (1): 27. Zablocka Tatjana, Kreismane Madara, Pjanova Dace, Isajevs Serge |
| Extracellular vesicle DNA from human melanoma tissues contains cancer-specific mutations. Frontiers in cell and developmental biology 2022 12 10 1028854. Crescitelli Rossella, Filges Stefan, Karimi Nasibeh, Urzì Ornella, Alonso-Agudo Tamara, Ståhlberg Anders, Lötvall Jan, Lässer Cecilia, Olofsson Bagge Rog |
| Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples. Cancers 2022 12 14 (23): . Gumà Josep, Peña Karla, Riu Francesc, Guilarte Carmen, Hernandez Anna, Lucía Clara, Martínez-Madueño Francisca, Miranda Maria José, Cabezas Inés, Grifoll Marc, Peralta Sergio, Serrano Sara, Muñoz Félix, Delamo Lola, Roig Barbara, Borràs Joan, Badia Joan, Rodriguez-Balada Marta, Parada Dav |
| Real-world outcomes using PD-1 antibodies and BRAF +?MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology : JEADV 2022 11 . Schumann Katharina, Mauch Cornelia, Klespe Kai-Christian, Loquai Carmen, Nikfarjam Ulrike, Schlaak Max, Akçetin Larissa, Kölblinger Peter, Hoellwerth Magdalena, Meissner Markus, Mengi Guelcin, Braun Andreas Dominik, Mengoni Miriam, Dummer Reinhard, Mangana Joanna, Sindrilaru Mihaela-Anca, Radmann Dan, Hafner Christine, Freund Johann, Rappersberger Klemens, Weihsengruber Felix, Meiss Frank, Reinhardt Lydia, Meier Friedegund, Rainer Barbara, Richtig Erika, Ressler Julia Maria, Höller Christoph, Eigentler Thomas, Amaral Teresa, Peitsch Wiebke K, Hillen Uwe, Harth Wolfgang, Ziller Fabian, Schatton Kerstin, Gambichler Thilo, Susok Laura, Maul Lara Valeska, Läubli Heinz, Debus Dirk, Weishaupt Carsten, Börger Sevil, Sievers Katharina, Haferkamp Sebastian, Zenderowski Veronika, Nguyen Van Anh, Wanner Marina, Gutzmer Ralf, Terheyden Patrick, Kähler Katharina, Emmert Steffen, Thiem Alexander, Sachse Michael, Gercken-Riedel Silke, Kaune Kjell Matthias, Thoms Kai-Martin, Heinzerling Lucie, Heppt Markus Vincent, Tratzmiller Sabine, Hoetzenecker Wolfram, Öllinger Angela, Steiner Andreas, Peinhaupt Tobias, Podda Maurizio, Schmid Sabine, Wollina Uwe, Biedermann Tilo, Posch Christi |
| Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor. Acta oncologica (Stockholm, Sweden) 2022 10 61 (10): 1263-1267. Mattila Kalle E, Mäkelä Siru, Kytölä Soili, Andersson Emma, Vihinen Pia, Ramadan Susan, Skyttä Tanja, Tiainen Leena, Vuoristo Meri-Sisko, Tyynelä-Korhonen Kristiina, Koivunen Jussi, Kohtamäki Laura, Aittomäki Kristiina, Hernberg Micae |
| BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population. Plastic and reconstructive surgery. Global open 2022 10 10 (10): e4605. Meevassana Jiraroch, Anothaisatapon Kullawit, Subbalekha Surawish, Kamolratanakul Supitcha, Siritientong Tippawan, Ruangritchankul Komkrit, Pungrasami Pornthep, Hamill Kevin J, Angsapatt Apichai, Kitkumthorn Nakar |
| Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019. Cureus 2022 10 14 (9): e29315. Masri Rim, Al Housseiny Amani, Aftimos George, Bitar Niz |
| Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & translational immunology 2023 8 12 (8): e1465. John Wen-Cheng Chang, Chien-Jung Huang, Wen-Kuan Huang, Yu-Chao Wang, Jia-Juan Hsieh, Yao-Yu Chang, Yen-Lin Huang, Chia-Ling Wu, Yeh-Han Wang, Shu-Jen Chen, Kien Thiam Tan, Chiao-Ping Chen, Chiao-En |
| Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. Cancer cell international 2023 8 23 (1): 187. Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo, Fang Wa |
| A real-world study of adjuvant anti-PD -1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations. Cancer medicine 2023 7 . Wei Sun, Yu Xu, WangJun Yan, ChunMeng Wang, Tu Hu, ZhiGuo Luo, XiaoWei Zhang, Xin Liu, Yong Ch |
| Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis. Research square 2023 7 . Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, Berit Gibson, Umang Swami, Alyssa Erickson-Wayman, Debra Jamison, Dan Sageser, Joanne Jeter, Tawnya Bowles, Donald M Cannon, Ben Haaland, Joyce D Schroeder, David Nix, Aaron Atkinson, John Hyngstrom, Jordan McPherson, Aik-Choon Tan, Siwen Hu-Lieskov |
| Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study. Frontiers in oncology 2023 7 13 1075823. Ryan C Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M Kirkwood, Greg M Delgoffe, Allison Betof Warner, Yana G Najj |
| Distinct senescence mechanisms restrain progression of dysplastic nevi. bioRxiv : the preprint server for biology 2023 7 . Franziska K Lorbeer, Gabrielle Rieser, Aditya Goel, Meng Wang, Areum Oh, Iwei Yeh, Boris C Bastian, Dirk Hockemey |
| Lack of Influence of Non-Overlapping Mutations in BRAF, NRAS, or NF1 on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma. Cancers 2023 7 15 (13): . Alyssa Panning, Wolfram Samlowski, Gabriel Allr |
| Primary Mucosal Melanoma of the Lip With GNA11 Mutation in a 23-Year-Old Pregnant Woman. Cureus 2023 6 15 (5): e38581. Shivam Khatri, Simon Kashfi, Stephanie Griff |
| Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. European journal of cancer (Oxford, England : 1990) 2023 6 . Oliver John Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U Blank, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C J van Akkooi, Caroline Robert, Alexander M M Eggermont, Paul Lorigan, Mario Manda |
| Contributions of replicative and translesion DNA polymerases to mutagenic bypass of canonical and atypical UV photoproducts. Nature communications 2023 5 14 (1): 2576. Brittany N Vandenberg, Marian F Laughery, Cameron Cordero, Dalton Plummer, Debra Mitchell, Jordan Kreyenhagen, Fatimah Albaqshi, Alexander J Brown, Piotr A Mieczkowski, John J Wyrick, Steven A Rober |
| Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors. Journal for immunotherapy of cancer 2023 5 11 (5): . Julia-Christina Stadler, Laura Keller, Christian Mess, Alexander T Bauer, Julian Koett, Glenn Geidel, Isabel Heidrich, Sabine Vidal-Y-Sy, Antje Andreas, Carlotta Stramaglia, Mark Sementsov, Wiebcke Haberstroh, Benjamin Deitert, Inka Lilott Hoehne, Robin Reschke, Thomas Haalck, Klaus Pantel, Christoffer Gebhardt, Stefan W Schneid |
| Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European journal of cancer (Oxford, England : 1990) 2023 5 188 140-151. Anne Zaremba, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Claudia Pföhler, Michael Weichenthal, Patrick Terheyden, Andrea Forschner, Ulrike Leiter, Jens Ulrich, Jochen Utikal, Julia Welzel, Martin Kaatz, Christoffer Gebhardt, Rudolf Herbst, Anca Sindrilaru, Edgar Dippel, Michael Sachse, Frank Meiss, Lucie Heinzerling, Sebastian Haferkamp, Carsten Weishaupt, Harald Löffler, Sophia Kreft, Klaus Griewank, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Lisa Zimm |
| Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases. Journal of cutaneous pathology 2023 5 . Keisuke Goto, Shusuke Yoshikawa, Toshihiro Takai, Kota Tachibana, Keiichiro Honma, Taiki Isei, Yoji Kukita, Takuma Ois |
| Role of Single Nucleotide Polymorphism-Related Genes in Tumour Immune Cell Infiltration and Prognosis of Cutaneous Melanoma. BioMed research international 2023 5 2023 3754094. Baihe Wang, Fanxiao Liu, Yuanyuan Li, Nan Ch |
| Comparative analysis of adjuvant therapy for stage III BRAF-mut melanoma: A real-world retrospective study from single center in China. Cancer medicine 2023 4 . Zhong Jingqin, Sun Wei, Hu Tu, Wang Chunmeng, Yan Wangjun, Luo Zhiguo, Liu Xin, Xu Yu, Chen Yo |
| Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter study. Journal of dermatological science 2023 4 . Inozume Takashi, Namikawa Kenjiro, Kato Hiroshi, Yoshikawa Shusuke, Kiniwa Yukiko, Yoshino Koji, Mizuhashi Satoru, Ito Takamichi, Takenouchi Tatsuya, Matsushita Shigeto, Fujisawa Yasuhiro, Matsuzawa Takamitsu, Sugihara Satoru, Asai Jun, Kitagawa Hiroshi, Maekawa Takeo, Isei Taiki, Yasuda Masahito, Yamazaki Naoya, Uhara Hisashi, Nakamura Yasuhi |
| Final analysis of a post-marketing surveillance study of dabrafenib and trametinib combination therapy in Japanese patients with unresectable malignant melanoma with BRAF V600 mutation. The Journal of dermatology 2023 3 . Kaizuka Tomoaki, Kurihara Ryohei, Harumiya Miki, Kimura Takayuki, Ushida Nao |
| Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases. The American Journal of dermatopathology 2023 3 . Mansour Boulos, Vanecek Tomas, Kastnerova Liubov, Nosek Daniel, Kazakov Dmitry V, Donati Miche |
| Malignant Melanoma in Older Adults: Different Patient or Different Disease? Cureus 2023 3 15 (2): e34742. Sasson Daniel C, Smetona John T, Parsaei Yassmin, Papageorge Marianna, Ariyan Stephan, Olino Kelly, Clune Jam |
| Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting. International journal of molecular sciences 2023 3 24 (5): . Vanni Irene, Pastorino Lorenza, Tanda Enrica Teresa, Andreotti Virginia, Dalmasso Bruna, Solari Nicola, Mascherini Matteo, Cabiddu Francesco, Guadagno Antonio, Coco Simona, Allavena Eleonora, Bruno William, Pietra Gabriella, Croce Michela, Gangemi Rosaria, Piana Michele, Zoppoli Gabriele, Ferrando Lorenzo, Spagnolo Francesco, Queirolo Paola, Ghiorzo Pao |
| Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma. Journal of translational medicine 2023 2 21 (1): 78. Huang Rong, Shen Gaigai, Ren Yu, Zheng Kelin, Wang Jiayu, Shi Yan, Yin Jiani C, Qin Lanqun, Zhang Guiying, Zhao Mengke, Su Xinyu, Li Luqiao, Wang Fufeng, Shao Yang, Liu Baorui, Zou Zhengy |
| Characterisation and outcome of RAC1 mutated melanoma. European journal of cancer (Oxford, England : 1990) 2023 2 183 1-10. Lodde Georg C, Jansen Philipp, Herbst Rudolf, Terheyden Patrick, Utikal Jochen, Pföhler Claudia, Ulrich Jens, Kreuter Alexander, Mohr Peter, Gutzmer Ralf, Meier Friedegund, Dippel Edgar, Weichenthal Michael, Sucker Antje, Placke Jan-Malte, Zaremba Anne, Albrecht Lea Jessica, Kowall Bernd, Galetzka Wolfgang, Becker Jürgen C, Tasdogan Alpaslan, Zimmer Lisa, Livingstone Elisabeth, Hadaschik Eva, Schadendorf Dirk, Ugurel Selma, Griewank Kla |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: